首页> 外文期刊>British Journal of Dermatology >Genetic polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR) and risk of vitiligo in Han Chinese populations: A genotype-phenotype correlation study
【24h】

Genetic polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR) and risk of vitiligo in Han Chinese populations: A genotype-phenotype correlation study

机译:亚族四氢叶酸还原酶基因(MTHFR)的遗传多态性与汉族人群白癜风的风险:基因型-表型相关性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background Recent evidence has revealed an elevation of total homocysteine (tHcy) in patients with vitiligo. Methylenetetrahydrofolate reductase (MTHFR) is one of the main enzymes regulating homocysteine (Hcy) metabolism. Thus, polymorphisms of MTHFR could potentially contribute to the development of vitiligo by affecting MTHFR activity and tHcy levels. Objectives To evaluate the potential association between MTHFR polymorphisms and vitiligo susceptibility. Methods In total, 1000 patients with vitiligo and 1000 age- and sex-matched controls were enrolled in this hospital-based case-control study. Two single-nucleotide polymorphisms of the MTHFR gene (rs1801133 C>T and rs1801131 A>C) were selected and genotyped using polymerase chain reaction (PCR)-restriction fragment length polymorphism and allele-specific PCR, respectively. The MTHFR activity concentration and tHcy level in serum were measured by enzyme-linked immunosorbent assay. Results We found that allele T of rs1801133 in the MTHFR gene was associated with a significantly reduced risk of vitiligo (adjusted odds ratio 0·58, 95% confidence interval 0·43-0·76, P < 0·001). In addition, the patients with vitiligo had a lower activity concentration of MTHFR and higher level of tHcy than the controls. Correlation between these markers and the risk of vitiligo was also observed. Furthermore, the individuals with a no-risk genotype (CT + TT) of rs1801133 and higher activity concentration of MTHFR or lower level of tHcy had a significantly decreased risk of vitiligo. Conclusions Our data suggest that MTHFR gene polymorphisms may play a vital role in genetic susceptibility to vitiligo. What's already known about this topic? Previous findings have suggested that patients with vitiligo have an elevated level of total homocysteine. Methylenetetrahydrofolate reductase (MTHFR) is an enzyme affecting homocysteine metabolism, and polymorphisms of the MTHFR gene impact the enzyme's activity. What does this study add? Our study demonstrates the association between functional mutations of the MTHFR gene and vitiligo susceptibility.
机译:背景技术最近的证据表明,白癜风患者总同型半胱氨酸(tHcy)升高。亚甲基四氢叶酸还原酶(MTHFR)是调节同型半胱氨酸(Hcy)代谢的主要酶之一。因此,MTHFR的多态性可能会通过影响MTHFR活性和tHcy水平来促进白癜风的发展。目的评估MTHFR多态性与白癜风易感性之间的潜在关联。方法这项基于医院的病例对照研究共纳入1000名白癜风患者以及1000名年龄和性别匹配的对照。选择MTHFR基因的两个单核苷酸多态性(rs1801133 C> T和rs1801131 A> C)并分别使用聚合酶链反应(PCR)-限制性片段长度多态性和等位基因特异性PCR进行基因分型。通过酶联免疫吸附测定法测定血清中的MTHFR活性浓度和tHcy水平。结果我们发现MTHFR基因中rs1801133的等位基因T与白癜风的风险显着降低有关(校正比值比为0·58,95%置信区间为0·43-0·76,P <0·001)。此外,白癜风患者的MTHFR活性浓度较低,tHcy水平高于对照组。还观察到这些标志物与白癜风风险之间的相关性。此外,具有rs1801133无风险基因型(CT + TT)且MTHFR活性浓度较高或tHcy水平较低的个体的白癜风风险显着降低。结论我们的数据表明MTHFR基因多态性可能在白癜风的遗传易感性中起重要作用。关于此主题的已知信息是什么?先前的发现表明白癜风患者的总同型半胱氨酸水平升高。亚甲基四氢叶酸还原酶(MTHFR)是一种影响同型半胱氨酸代谢的酶,MTHFR基因的多态性会影响该酶的活性。这项研究增加了什么?我们的研究表明MTHFR基因的功能性突变与白癜风易感性之间的关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号